Hospital for Special Surgery

History Made: Congratulations to the NY LIBERTY on winning their first championship in franchise history, and the first New York basketball championship in 51 years! As the Official Hospital of the Liberty, HSS was proud to celebrate this momentous occasion with thousands at yesterday’s victory parade at the Canyon of Heroes in New York City. 

I had the privilege of attending #ICHOM2024 in Amsterdam with my Hospital for Special Surgery colleagues, Catherine MacLean, MD PhD and Amy Chin. We were selected to display our poster, "Cost, Utilization, and Outcomes for Revision Total Hip and Knee Arthroplasty by Pre-Operative Indication," in the Abstract Gallery, for a global audience of healthcare leaders to view in person. The conference fostered rich discussions on advancing healthcare through patient-reported outcome measures (PROMs), with a focus on their role in revolutionizing care, payment models, and policy. A key session was the World Economic Forum's roundtable on transforming healthcare through value-based models, where global leaders explored public-private partnerships, financing for value, VBHC change models, and leveraging digital and data utility. Engaging with leaders from around the world to address these questions was invaluable. Another great session, "PROMs: How to Walk the Talk," was a collaborative workshop where we explored strategies for harmonizing PROMs, improving selection and prioritization, and enhancing data visualization and sharing to support shared decision-making. I am eager to bring these insights back to HSS to continue shaping high-value, patient-centered care! #ICHOM2024 #ValuebasedHealthcare #PatientCenteredOutcomes #PROMs International Consortium for Health Outcomes Measurement (ICHOM)

Congratulations to Bashir Agboola for being named one of Crain's New York Business 2024 Notable Black Leaders in Healthcare. As Vice President, Associate Chief Information Officer and Chief Technology Officer at HSS, Agboola has successfully led technology initiatives that have enabled many business transformation efforts at HSS. His technology leadership during the Covid-19 pandemic ensured smooth patient care through the rapid scaling of technology infrastructure. Agboola is a board member at the Center for Family Support, has won industry awards, including the HMG Strategy Global Leadership Institute Award, and writes on technology and leadership topics. https://lnkd.in/evTXNcRh

Congratulations to Daphne A. Scott, MD, sports medicine physician in the HSS Women’s Sports Medicine Center and Lead Team Physician for the New York Knicks, who has been appointed as Chief of the Primary Sports Medicine Service, effective December 1. “I am honored and thrilled to take on this new role,” Dr. Scott said. “Our Primary Sports Medicine Service is renowned worldwide for its expertise, innovation and superior care. I look forward to building upon the team’s already exceptional foundation.” “Dr. Scott’s steadfast commitment to her patients and the population at large will be an asset to her role as Chief,” said Bryan T. Kelly, MD, MBA, president and CEO at HSS. “We are excited to see how the department flourishes under her leadership.” https://lnkd.in/eYCGpUeh

HSS Honors Respiratory Care Week Respiratory therapy is the health care discipline that specializes in the promotion of optimum pulmonary function, health, and wellness. Respiratory therapists utilize their knowledge and understanding of the scientific principles underlying cardiopulmonary physiology and pathophysiology, as well as the biomedical engineering and application of technology, to provide direct and indirect respiratory care services effectively across all care settings. The practice of respiratory care encompasses activities in: diagnostic evaluation, therapy, disease management and education of the patient, family, and public in lung and breathing disorders/diseases. Please join us in celebrating and recognizing the vital contributions that our respiratory therapists provide to our patients and medical staff at HSS.

Sterile Processing Week recognizes the committed specialists who make a positive difference in patient care. At HSS, our Central Sterile Processing (CSP) team pride themselves in being engaged and compliant to regulatory standards for quality and patient safety to deliver the best service and products for our patients. Congratulations to the dedicated members of the CSP team!

In a study conducted at HSS, researchers found that patients with obstructive sleep apnea (OSA) who used continuous positive airway pressure (CPAP) therapy before total hip and knee replacement surgery significantly reduced their risk for complications after surgery compared with OSA patients who did not use CPAP therapy before surgery. These findings were presented at the Society of Anesthesia and Sleep Medicine SASM HQ 14th annual meeting. “Obstructive sleep apnea affects 40 million adults in the United States and is associated with an increased complication risk among patients undergoing surgery,” said Stavros Memtsoudis, MD, PhD, Anesthesiologist-in-Chief and Chair of the HSS Department of Anesthesiology, Critical Care & Pain Management. “These findings are significant as they support the notion that adhering to these guidelines can benefit OSA patients undergoing surgery,” said Jashvant Poeran, MD, PhD, Director of Research in the HSS Department of Anesthesiology, Critical Care & Pain Management. “While we had anticipated these results based on the guidelines, this is the first study to demonstrate this on such a large scale.” https://brnw.ch/21wNTW4

At HSS, we are proud to recognize and celebrate National Disability Employment Awareness Month (NDEAM) this October. NDEAM highlights the valuable contributions of workers with disabilities and promotes inclusive employment practices. Our commitment to fostering an accessible and inclusive workplace is part of our broader mission to support diversity, equity, and inclusion at all levels. We strive to create a welcoming environment where employees of all abilities are empowered to thrive. This includes ensuring equitable opportunities for career growth, cultivating a culture of respect, and providing resources for accessibility and support. Key Initiatives at HSS: - Accessible work environments and technology to support employees with disabilities. - Training and education programs for staff to foster a culture of inclusion and awareness. - Commitment to inclusive hiring practices that provide opportunities for all individuals, regardless of ability. As we celebrate #NDEAM, we honor the contributions of our colleagues with disabilities and reaffirm our dedication to an inclusive workforce. Let’s continue to work together to break down barriers and build a community where everyone has the opportunity to succeed.

In celebration of National Hispanic Heritage Month, the Hispanic Organization for Leadership & Advancement (HOLA) ERG at HSS led incredible events that showcased the richness of Hispanic/Latinx culture and contributions. The kick-off was Café con HOLA, a series in which Hispanic/Latinx leaders within HSS shared their insights on professional development & leadership. Additionally, the United for Health Equity: Addressing Disparities with the Hispanic Federation program highlighted the importance of addressing health disparities in our communities by sharing strategies to improve access to care, raise awareness, and promote culturally competent healthcare practices. Lastly, the Noche de Estrellas Talent Show included powerful poetry readings, song, and dance performances from HSS employees and community-based Dominican and Ecuadorian folklore groups. This was a beautiful celebration of culture and talent across our community.  These events provided meaningful opportunities to connect in real time and honor the diversity that enriches our organization. Throughout the rest of the month’s festivities, stunning wall displays were made across HSS locations that honored influential Hispanic figures and their contributions. Thank you to everyone who joined in these memorable celebrations!

SciRhom, a biotech startup co-founded by HSS, recently secured $70 million Series A financing round to support the clinical development of its novel drug candidate, SR-878. This news follows the company’s recently received approval from Austrian regulatory authorities (BASG/AGES) required to commence its first-in-human Phase I clinical trial in Europe this fall. SR-878, which builds upon foundational basic research discoveries made in the lab of Carl P. Blobel, MD, PhD, director of the Arthritis and Tissue Degeneration Program at the HSS Research Institute, is a monoclonal antibody drug candidate that targets inflammation in a new way. The development of SR-878 underscores the importance of doing basic science research at academic institutions like HSS,” says Michael P. Ast, MD, orthopedic surgeon and Chief Medical Innovation Officer at HSS. “SciRhom’s recent Series A financing and its approval to start clinical trials are pivotal milestones in the company’s journey towards commercialization” says Vijay Nair, Managing Director at the HSS Innovation Institute. https://lnkd.in/eu4BqCzs